วันพุธที่ 17 มิถุนายน พ.ศ. 2558

Is Your Dog or Cat Suffering in Silence From Joint Discomfort? (Sponsored Bite)

A great offer for you and your dog!
View this email in your browser

ProJoint

Sponsored Bite l June 16, 2015

Is Your Dog or Cat Suffering in Silence From Joint Discomfort?

America's top veterinarian reveals the breakthrough that can end your pet's suffering safely and naturally
 

Don't let joint discomfort steal years from your beloved dog or cat and rob you of a companion who's such a big part of your family.

ProJoint PLUS™ is an advanced, multi-ingredient joint support formula designed specifically with your pet's needs in mind.

Developed by Stop Aging Now in conjunction with renowned veterinarian Dr. Katy Nelson, ProJoint PLUS contains powerful, therapeutic doses of Provinal® Omega-7 and hyaluronic acid, natural ingredients that have been scientifically shown to support cartilage health, promote a healthy inflammatory response, and fight free radical damage.

ProJoint PLUS is made to the same specifications as human supplements and human pharmaceutical drugs and is produced in the U.S. in a state-of-the-art FDA-inspected facility.

And unlike prescription pain drugs that can result in serious gastrointestinal and liver damage, as well as other unwanted side effects, ProJoint PLUS is safe, 100% natural, and can be taken on a daily basis to promote a healthy inflammatory response and improve joint comfort.

Each delicious chewy treat includes a clinical dose of 105 mg of Provinal® Omega-7 plus a potent 15 mg dose of hyaluronic acid (HA), standardized to the highest level of purity.

To end your pet's suffering, CLICK HERE to learn more about ProJoint PLUS.    
Order Now
Forward
Share
Tweet
Copyright © 2015 Modern Dog Inc, All rights reserved.
You are receiving this email because you opt-ed in to our enewsletter through our website, through a giveaway contest, or via your subscription.*
To view our advertising policy, click here. 

unsubscribe from this list    update subscription preferences 

 

ไม่มีความคิดเห็น:

แสดงความคิดเห็น